Marina Richardson, PhD, MSc

Associate Director, HTA Methods and Health Economics

Marina is ICER’s Associate Director of HTA Methods and Health Economics. Prior to coming to ICER, Marina spent 7 years at CADTH (the Canadian Agency for Drugs and Technologies in Health) where she contributed to over 30 drug reimbursement review reports and recommendations. Marina has a well-rounded appreciation for health technology assessment (HTA) having been involved in appraising clinical evidence, economic evidence, and contributing to HTA-related process development for biosimilars and deliberative processes.

Marina completed an MSc in Epidemiology and Biostatistics at Western University, and a PhD in Health Services Research, HTA stream at the University of Toronto in Canada. In her spare time, Marina enjoys connecting with family, friends, and colleagues, playing sports, spending time at the cottage, and traveling.